Pegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera

Basit Öğe Kaydı
dc.contributor.authorEkinci, O.
dc.date.accessioned2026-08-12T17:25:50Z
dc.date.issued2019
dc.departmentFırat Üniversitesi
dc.description10th Eurasian Hematology Oncology Congress -- OCT 08-11, 2019 -- Istanbul, TURKEY
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1016/S0145-2126(19)30261-9
dc.identifier.endpageS27
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS27
dc.identifier.urihttps://doi.org/10.1016/S0145-2126(19)30261-9
dc.identifier.urihttps://hdl.handle.net/11508/54555
dc.identifier.volume85
dc.identifier.wosWOS:000489290100022
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherPergamon-Elsevier Science Ltd
dc.relation.ispartofLeukemia Research
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titlePegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu